Maguette Sylla Niang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maguette Sylla Niang has a total of 224 co-authors. Here are the top co-authors by number of shared publications:
Alioune Dieye
Department of Immunology, Faculty of Medicine, Pharmacy and Odontology, UCAD, Dakar, Senegal
5 shared publicationsBabacar Mbengue
Department of Immunology, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University of Dakar, Dakar, Senegal
4 shared publicationsP A Diop
4 shared publications- Babacar Mbengue
Service d'Immunologie FMPO, Université Cheikh Anta Diop de Dakar, Dakar, Senegal
3 shared publications Birahim Niang
Service de Réanimation, Hôpital Principal de Dakar, HPD, Senegal
3 shared publicationsMouhamadou Mansour Fall
Service de Réanimation, Hôpital Principal de Dakar, HPD, Senegal
3 shared publications
Latest Publications
- Open Access
A cell surface proteomic atlas reveals socioeconomic status associated immune diversity
Socioeconomic status (SES) is a potent determinant of immune variation, yet unbiased approaches to holistically map the effect of SES on the immune system are lacking. We developed a high-dimensional flow cytometry-based profiling approach to analyse 331 cell surface proteins across 33 immune cell subsets within an SES-stratified Senegalese cohort, alongside a European cohort (Netherlands). We identified 108 SES-related markers across the immune system, revealing that lower SES individuals exhibited downregulation of surface proteins, affecting in particular adhesins, chemokine and complement receptors. Conversely, lower SES was associated with hallmarks of chronic activation and exhaustion including upregulation of immune checkpoints. Metabolic profiling demonstrated that while lower SES individuals displayed elevated baseline RNA transcription, higher SES individuals exhibited superior protein translation rates. We validated these SES-related immune trends in an independent cohort and provide an interactive online resource for exploring this surface protein atlas on immune cell subsets. Taken together, these findings provide a global overview of how the cell surface proteome varies by SES, and identify molecular changes that can affect vaccine efficacy and disease outcomes.
Open AccessA cell surface proteomic atlas reveals socioeconomic status associated immune diversity
Socioeconomic status (SES) is a potent determinant of immune variation, yet unbiased approaches to holistically map the effect of SES on the immune system are lacking. We developed a high-dimensional flow cytometry-based profiling approach to analyse 331 cell surface proteins across 33 immune cell subsets within an SES-stratified Senegalese cohort, alongside a European cohort (Netherlands). We identified 108 SES-related markers across the immune system, revealing that lower SES individuals exhibited downregulation of surface proteins, affecting in particular adhesins, chemokine and complement receptors. Conversely, lower SES was associated with hallmarks of chronic activation and exhaustion including upregulation of immune checkpoints. Metabolic profiling demonstrated that while lower SES individuals displayed elevated baseline RNA transcription, higher SES individuals exhibited superior protein translation rates. We validated these SES-related immune trends in an independent cohort and provide an interactive online resource for exploring this surface protein atlas on immune cell subsets. Taken together, these findings provide a global overview of how the cell surface proteome varies by SES, and identify molecular changes that can affect vaccine efficacy and disease outcomes.
- 1 December 2021
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie - FMC
- Vol. 1 (8) , A207
Manifestations dermatologiques au cours des déficits immunitaires primitifs à Dakar
- 1 December 2021
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie - FMC
- Vol. 1 (8) , A207
Manifestations dermatologiques au cours des déficits immunitaires primitifs à Dakar
- 10 September 2020
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 20 (10) , 594-602
The global response to the COVID-19 pandemic: how have immunology societies contributed?
The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- 10 September 2020
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 20 (10) , 594-602
The global response to the COVID-19 pandemic: how have immunology societies contributed?
The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- Open Access
- 31 January 2020
- Published by Springer Nature in npj Genomic Medicine
- Vol. 5 (1) , 1-6
Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal
BRCA1 and BRCA2 are the most incriminated genes in inherited breast/ovarian cancers. Several pathogenic variants of these genes conferring genetic predisposition have been described in different populations but rarely in sub-Saharan Africa. The objectives of this study were to identify pathogenic variants of the BRCA genes involved in hereditary breast cancer in Senegal and to search for a founder effect. We recruited after free informed consent, 27 unrelated index cases diagnosed with breast cancer and each having a family history. Mutation screening of the genes identified a duplication of ten nucleotides c.815_824dupAGCCATGTGG, (p.Thr276Alafs) (NM_007294.3) located in exon 11 of BRCA1 gene, in 15 index cases (allelic frequency 27.7%). The pathogenic variant has been previously reported in African Americans as a founder mutation of West African origin. Haplotypes analysis of seven microsatellites surrounding the BRCA1 gene highlights a shared haplotype encompassing ~400 kb between D17S855 and D17S1325. This haplotype was not detected in none of 15 healthy controls. Estimation of the age of the pathogenic variant suggested that it occurred ~1400 years ago. Our study identified a founder pathogenic variant of BRCA1 predisposing to breast cancer and enabled the establishment of an affordable genetic test as a mean of prevention for Senegalese women at risk.
- 31 January 2020
- Published by Springer Nature in npj Genomic Medicine
- Vol. 5 (1) , 1-6
Open AccessEvidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal
BRCA1 and BRCA2 are the most incriminated genes in inherited breast/ovarian cancers. Several pathogenic variants of these genes conferring genetic predisposition have been described in different populations but rarely in sub-Saharan Africa. The objectives of this study were to identify pathogenic variants of the BRCA genes involved in hereditary breast cancer in Senegal and to search for a founder effect. We recruited after free informed consent, 27 unrelated index cases diagnosed with breast cancer and each having a family history. Mutation screening of the genes identified a duplication of ten nucleotides c.815_824dupAGCCATGTGG, (p.Thr276Alafs) (NM_007294.3) located in exon 11 of BRCA1 gene, in 15 index cases (allelic frequency 27.7%). The pathogenic variant has been previously reported in African Americans as a founder mutation of West African origin. Haplotypes analysis of seven microsatellites surrounding the BRCA1 gene highlights a shared haplotype encompassing ~400 kb between D17S855 and D17S1325. This haplotype was not detected in none of 15 healthy controls. Estimation of the age of the pathogenic variant suggested that it occurred ~1400 years ago. Our study identified a founder pathogenic variant of BRCA1 predisposing to breast cancer and enabled the establishment of an affordable genetic test as a mean of prevention for Senegalese women at risk.
- Open Access
- 25 March 2019
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 32, 140
Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level
Introduction: Hepatitis B virus (HBV) infection is highly endemic in Senegal. HBV vaccine of all children has been introduced in 1999 and included in the Expanded Programme on Immunization in 2004. The aim of this study was to assess the HBV prevalence and immunity status against HBV amongst children in Senegal. Methods: Between March and August 2016, consecutive children aged from 6 months to 16 years old were recruited in outpatient department of three main children hospitals in Senegal. Serum samples were analyzed for HBV serology (HBsAg, HBsAb, HBsAb) using ARCHITECT analyzer. Children with HBsAb levels >= 10 IU/l) were considered as seroprotected against HBV. Results: During the study period, 295 children fulfilled the criteria for the study and were further analyzed. Three children were HBsAg positive giving a seroprevalence at 1.1% (95% CI: 0.2-3.3), 12/267 (4.5%, 95% CI=2.3-7.7) had positive HBsAb and 226/295 (76.6%, 71.4-81.3) had positive HBsAb including 191 (77.3%, 71.6-82.4) with isolated HBsAb related to previous active immunization. However only 165 children (56%, CI 50-62) had seroprotective HBsAb levels (HBsAb >= 10 UI/L) and 63 (21.4, 16.8-26) had a strong seroprotectiondefined by HBsAb >= 100 IU/L. Conclusion: Our results suggest that although HBV prevalence has significantly decreased in children in Senegal following a better HBV vaccine coverage, the number of children correctly seroprotected is insufficient (56%). Assessing the levels of HBsAb and providing HBV vaccine boosters should be considered in children in Senegal.
- 25 March 2019
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 32, 140
Open AccessHepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level
Introduction: Hepatitis B virus (HBV) infection is highly endemic in Senegal. HBV vaccine of all children has been introduced in 1999 and included in the Expanded Programme on Immunization in 2004. The aim of this study was to assess the HBV prevalence and immunity status against HBV amongst children in Senegal. Methods: Between March and August 2016, consecutive children aged from 6 months to 16 years old were recruited in outpatient department of three main children hospitals in Senegal. Serum samples were analyzed for HBV serology (HBsAg, HBsAb, HBsAb) using ARCHITECT analyzer. Children with HBsAb levels >= 10 IU/l) were considered as seroprotected against HBV. Results: During the study period, 295 children fulfilled the criteria for the study and were further analyzed. Three children were HBsAg positive giving a seroprevalence at 1.1% (95% CI: 0.2-3.3), 12/267 (4.5%, 95% CI=2.3-7.7) had positive HBsAb and 226/295 (76.6%, 71.4-81.3) had positive HBsAb including 191 (77.3%, 71.6-82.4) with isolated HBsAb related to previous active immunization. However only 165 children (56%, CI 50-62) had seroprotective HBsAb levels (HBsAb >= 10 UI/L) and 63 (21.4, 16.8-26) had a strong seroprotectiondefined by HBsAb >= 100 IU/L. Conclusion: Our results suggest that although HBV prevalence has significantly decreased in children in Senegal following a better HBV vaccine coverage, the number of children correctly seroprotected is insufficient (56%). Assessing the levels of HBsAb and providing HBV vaccine boosters should be considered in children in Senegal.
- 23 December 2018
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 196 (1) , 86-96
Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes
Merozoite surface proteins (MSPs) are critical for parasite invasion, they represent attractive targets for antibody‐based protection against clinical malaria. To identify protection‐associated target MSPs, the present study analyzed antibody responses to whole merozoite extract (ME) and to defined MSP recombinant antigens in hospitalized patients from a low endemic urban area as a function of disease severity (mild vs cerebral malaria). Sera from 110 patients with confirmed severe cerebral malaria (CM) and 91 patients with mild malaria (MM) were analyzed (mean age 29 years) for total and subclass IgG to ME and total IgG to MSP1p19, MSP2, MSP3, MSP4 and MSP5 by ELISA. Functional antibody responses were evaluated using the antibody dependent respiratory burst (ADRB) assay in a subset of sera. There was a trend toward higher IgG1 and IgG4 levels to ME in CM compared to MM, only ME IgM responses differed significantly between fatal and surviving CM patients. Increased prevalence of IgG to individual MSPs was found in the CM compared to the MM group including significantly higher levels of IgG to MSP4 and MSP5 in the former. Sera from fatal (24.5%) vs surviving cases showed significantly lower IgG to MSP1p19 and MSP3 (P<0.05). ADRB assay readouts correlated with high levels of anti‐MSP IgG, and trended higher in sera from patients with surviving compared to fatal CM outcome (P=0.07). These results document strong differential antibody responses to MSP antigens as targets of protective immunity against CM and in particular MSP1p19 and MSP3 as prognostic indicators.
- 23 December 2018
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 196 (1) , 86-96
Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes
Merozoite surface proteins (MSPs) are critical for parasite invasion, they represent attractive targets for antibody‐based protection against clinical malaria. To identify protection‐associated target MSPs, the present study analyzed antibody responses to whole merozoite extract (ME) and to defined MSP recombinant antigens in hospitalized patients from a low endemic urban area as a function of disease severity (mild vs cerebral malaria). Sera from 110 patients with confirmed severe cerebral malaria (CM) and 91 patients with mild malaria (MM) were analyzed (mean age 29 years) for total and subclass IgG to ME and total IgG to MSP1p19, MSP2, MSP3, MSP4 and MSP5 by ELISA. Functional antibody responses were evaluated using the antibody dependent respiratory burst (ADRB) assay in a subset of sera. There was a trend toward higher IgG1 and IgG4 levels to ME in CM compared to MM, only ME IgM responses differed significantly between fatal and surviving CM patients. Increased prevalence of IgG to individual MSPs was found in the CM compared to the MM group including significantly higher levels of IgG to MSP4 and MSP5 in the former. Sera from fatal (24.5%) vs surviving cases showed significantly lower IgG to MSP1p19 and MSP3 (P<0.05). ADRB assay readouts correlated with high levels of anti‐MSP IgG, and trended higher in sera from patients with surviving compared to fatal CM outcome (P=0.07). These results document strong differential antibody responses to MSP antigens as targets of protective immunity against CM and in particular MSP1p19 and MSP3 as prognostic indicators.
- Open Access
- 4 August 2017
- Published by Hindawi Limited in Global Health, Epidemiology and Genomics
- Vol. 2, e10
Strengthening human genetics research in Africa: report of the 9th meeting of the African Society of Human Genetics in Dakar in May 2016
The 9th meeting of the African Society of Human Genetics, in partnership with the Senegalese Cancer Research and Study Group and the Human Heredity and Health in Africa (H3Africa) Consortium, was held in Dakar, Senegal. The theme wasStrengthening Human Genetics Research in Africa.The 210 delegates came from 21 African countries and from France, Switzerland, UK, UAE, Canada and the USA. The goal was to highlight genetic and genomic science across the African continent with the ultimate goal of improving the health of Africans and those across the globe, and to promote the careers of young African scientists in the field. A session on the sustainability of genomic research in Africa brought to light innovative and practical approaches to supporting research in resource-limited settings and the importance of promoting genetics in academic, research funding, governmental and private sectors. This meeting led to the formation of the Senegalese Society for Human Genetics.
- 4 August 2017
- Published by Hindawi Limited in Global Health, Epidemiology and Genomics
- Vol. 2, e10
Open AccessStrengthening human genetics research in Africa: report of the 9th meeting of the African Society of Human Genetics in Dakar in May 2016
The 9th meeting of the African Society of Human Genetics, in partnership with the Senegalese Cancer Research and Study Group and the Human Heredity and Health in Africa (H3Africa) Consortium, was held in Dakar, Senegal. The theme wasStrengthening Human Genetics Research in Africa.The 210 delegates came from 21 African countries and from France, Switzerland, UK, UAE, Canada and the USA. The goal was to highlight genetic and genomic science across the African continent with the ultimate goal of improving the health of Africans and those across the globe, and to promote the careers of young African scientists in the field. A session on the sustainability of genomic research in Africa brought to light innovative and practical approaches to supporting research in resource-limited settings and the importance of promoting genetics in academic, research funding, governmental and private sectors. This meeting led to the formation of the Senegalese Society for Human Genetics.
- Open Access
- 3 August 2016
- Published by Wiley in BioMed Research International
- Vol. 2016, 1-11
Relationship between Antibody Levels, IgG Binding toPlasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal
Background. Management of clinical malaria requires the development of reliable diagnostic methods and efficient biomarkers for follow-up of patients. Protection is partly based on IgG responses to parasite antigens exposed at the surface of infected erythrocytes (iRBCs). These IgG responses appeared low during clinical infection, particularly in severe disease.Methods. We analyzed the IgG binding capacity to the surface of live erythrocytes infected by knob positive FCR3 strain. Sera from 69 cerebral malaria (CM) and 72 mild malaria (MM) cases were analyzed by ELISA for IgG responses to five antigens from iRBC and by flow cytometry for IgG binding as expressed in labeling index ratio (LIR). The relationship between IgG levels, LIR, parasitemia, age, and the clinical outcomes was evaluated.Results. We found a significant decrease of LIR in adult CM fatal cases compared to surviving patients (). In MM, LIRs were correlated to IgG anti-iRBC and anti-PfEMP3/5 levels. In CM, no correlation was found between LIR, IgG levels, and parasitemia.Conclusion. The IgG binding assay was able to discriminate outcome of cerebral malaria cases and it deserves further development as a potential functional-associated assay for symptomatic malaria analysis.- 3 August 2016
- Published by Wiley in BioMed Research International
- Vol. 2016, 1-11
Open AccessRelationship between Antibody Levels, IgG Binding toPlasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal
Background. Management of clinical malaria requires the development of reliable diagnostic methods and efficient biomarkers for follow-up of patients. Protection is partly based on IgG responses to parasite antigens exposed at the surface of infected erythrocytes (iRBCs). These IgG responses appeared low during clinical infection, particularly in severe disease.Methods. We analyzed the IgG binding capacity to the surface of live erythrocytes infected by knob positive FCR3 strain. Sera from 69 cerebral malaria (CM) and 72 mild malaria (MM) cases were analyzed by ELISA for IgG responses to five antigens from iRBC and by flow cytometry for IgG binding as expressed in labeling index ratio (LIR). The relationship between IgG levels, LIR, parasitemia, age, and the clinical outcomes was evaluated.Results. We found a significant decrease of LIR in adult CM fatal cases compared to surviving patients (). In MM, LIRs were correlated to IgG anti-iRBC and anti-PfEMP3/5 levels. In CM, no correlation was found between LIR, IgG levels, and parasitemia.Conclusion. The IgG binding assay was able to discriminate outcome of cerebral malaria cases and it deserves further development as a potential functional-associated assay for symptomatic malaria analysis. - Open Access
- 11 May 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0154000
Evaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal
HIV infection is a concern in the army troupes because of the risk behaviour of the military population. In order to allow regular access to CD4+ T cell enumeration of military personnel as well as their dependents and civilians living with HIV, the Senegalese Army AIDS program is implementing PIMATM Alere technology in urban and semi-urban military medical centres. Validation such device is therefore required prior their wide implementation. The purpose of this study was to compare CD4+ T cell count measurements between the PIMATM Alere to the BD FACSCountTM. We selected a total of 200 subjects including 50 patients with CD4+ T-cells below 200/mm3, 50 between 200 and 350/mm3, 50 between 351 and 500/mm3, and 50 above 500/mm3. CD4+ T-cell count was performed on venous blood using the BD FASCountTM as reference method and the PIMATM Point of Care technology. The mean biases and limits of agreement between the PIMATM Alere and BD FACSCountTM were assessed with the Bland-Altman analysis, the linear regression performed using the Passing-Bablok regression analysis, and the percent similarity calculated using the Scott method. Our data have shown a mean difference of 22.3 cells/mm3 [95%CI:9.1–35.5] between the BD FACSCountTM and PIMATM Alere CD4 measurements. However, the mean differences of the two methods was not significantly different to zero when CD4+ T-cell count was below 350/mm3 (P = 0.76). The Passing-Bablok regression in categorized CD4 counts has also showed concordance correlation coefficient of 0.89 for CD4+ T cell counts below 350/mm3 whilst it was 0.5 when CD4 was above 350/mm3. Overall, our data have shown that for low CD4 counts, the results from the PIMATM Alere provided accurate CD4+ T cell counts with a good agreement compared to the FACSCountTM.
- 11 May 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0154000
Open AccessEvaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal
HIV infection is a concern in the army troupes because of the risk behaviour of the military population. In order to allow regular access to CD4+ T cell enumeration of military personnel as well as their dependents and civilians living with HIV, the Senegalese Army AIDS program is implementing PIMATM Alere technology in urban and semi-urban military medical centres. Validation such device is therefore required prior their wide implementation. The purpose of this study was to compare CD4+ T cell count measurements between the PIMATM Alere to the BD FACSCountTM. We selected a total of 200 subjects including 50 patients with CD4+ T-cells below 200/mm3, 50 between 200 and 350/mm3, 50 between 351 and 500/mm3, and 50 above 500/mm3. CD4+ T-cell count was performed on venous blood using the BD FASCountTM as reference method and the PIMATM Point of Care technology. The mean biases and limits of agreement between the PIMATM Alere and BD FACSCountTM were assessed with the Bland-Altman analysis, the linear regression performed using the Passing-Bablok regression analysis, and the percent similarity calculated using the Scott method. Our data have shown a mean difference of 22.3 cells/mm3 [95%CI:9.1–35.5] between the BD FACSCountTM and PIMATM Alere CD4 measurements. However, the mean differences of the two methods was not significantly different to zero when CD4+ T-cell count was below 350/mm3 (P = 0.76). The Passing-Bablok regression in categorized CD4 counts has also showed concordance correlation coefficient of 0.89 for CD4+ T cell counts below 350/mm3 whilst it was 0.5 when CD4 was above 350/mm3. Overall, our data have shown that for low CD4 counts, the results from the PIMATM Alere provided accurate CD4+ T cell counts with a good agreement compared to the FACSCountTM.
- 29 March 2016
- Published by Lavoisier in Bulletin de la Société de pathologie exotique
- Vol. 109 (2) , 91-98
Profils des réponses IgG dirigées contre CSP, GLURP et LSA-3NR2 dans le paludisme urbain à Dakar : influence sur l’hémoglobinémie et les parasitémies circulantes
Plusieurs candidats vaccins contre le paludisme à Plasmodium falciparum sont à diverses phases d’essais cliniques en zone rurale à forte endémicité palustre. Très peu d’études ont concerné les grandes villes. L’urbanisation rapide des populations africaines requiert la poursuite des investigations concernant le paludisme dans ces villes. Cette étude a consisté en une évaluation par ELISA des taux d’IgG dirigées contre les antigènes CSP, LSA-3NR2 et GLURP de P. falciparum. Elle a été faite chez 144 patients dakarois consultant pour un accès palustre (non aggravé). L’âge moyen était de 15 ans (4-65). Les patients étaient répartis en 59 adultes (< 15 ans) et 85 enfants (≤ 15 ans). Les parasitémies allant de 0,01 à 15 %, n’étaient pas variables suivant l’âge contrairement aux taux d’hémoglobine (4,5-16,6 g/dl) plus faibles chez les enfants (p < 0,01). Au plan immunologique, GLURP et CSP étaient plus reconnus que LSA- 3NR2. Les taux d’IgG anti-GLURP et anti-CSP sont apparus discriminants suivant l’âge avec globalement une corrélation positive (rho= 0,32; p < 0,001). Seuls les niveaux d’IgG anti-GLURP étaient associés aux faibles parasitémies (≤ 1 %) et aux taux élevés d’hémoglobinémie (≥ 11 g/dl), surtout chez les adultes (p < 0,001). Dans une analyse de régression multiple, aucune des réponses contre les antigènes testés n’a été associée aux parasitémies. Nos résultats montrent l’implication des IgG anti-GLURP dans l’immunité humorale antiparasitaire. L’apport de ce travail est d’avoir contribué à déterminer des niveaux d’IgG pouvant servir de biomarqueurs du statut clinique dans le paludisme urbain.
- 29 March 2016
- Published by Lavoisier in Bulletin de la Société de pathologie exotique
- Vol. 109 (2) , 91-98
Profils des réponses IgG dirigées contre CSP, GLURP et LSA-3NR2 dans le paludisme urbain à Dakar : influence sur l’hémoglobinémie et les parasitémies circulantes
Plusieurs candidats vaccins contre le paludisme à Plasmodium falciparum sont à diverses phases d’essais cliniques en zone rurale à forte endémicité palustre. Très peu d’études ont concerné les grandes villes. L’urbanisation rapide des populations africaines requiert la poursuite des investigations concernant le paludisme dans ces villes. Cette étude a consisté en une évaluation par ELISA des taux d’IgG dirigées contre les antigènes CSP, LSA-3NR2 et GLURP de P. falciparum. Elle a été faite chez 144 patients dakarois consultant pour un accès palustre (non aggravé). L’âge moyen était de 15 ans (4-65). Les patients étaient répartis en 59 adultes (< 15 ans) et 85 enfants (≤ 15 ans). Les parasitémies allant de 0,01 à 15 %, n’étaient pas variables suivant l’âge contrairement aux taux d’hémoglobine (4,5-16,6 g/dl) plus faibles chez les enfants (p < 0,01). Au plan immunologique, GLURP et CSP étaient plus reconnus que LSA- 3NR2. Les taux d’IgG anti-GLURP et anti-CSP sont apparus discriminants suivant l’âge avec globalement une corrélation positive (rho= 0,32; p < 0,001). Seuls les niveaux d’IgG anti-GLURP étaient associés aux faibles parasitémies (≤ 1 %) et aux taux élevés d’hémoglobinémie (≥ 11 g/dl), surtout chez les adultes (p < 0,001). Dans une analyse de régression multiple, aucune des réponses contre les antigènes testés n’a été associée aux parasitémies. Nos résultats montrent l’implication des IgG anti-GLURP dans l’immunité humorale antiparasitaire. L’apport de ce travail est d’avoir contribué à déterminer des niveaux d’IgG pouvant servir de biomarqueurs du statut clinique dans le paludisme urbain.